Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Liabilities from Discontinued Operations (2018 - 2019)

Plus Therapeutics (PSTV) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 2102000.0 as the latest value for Q2 2019.

  • On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 2102000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was 2102000.0, a N/A change, with the full-year FY2018 number at 580000.0, changed N/A from a year prior.
  • Liabilities from Discontinued Operations was 2102000.0 for Q2 2019 at Plus Therapeutics, up from 580000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 2102000.0 in Q2 2019 to a low of 580000.0 in Q4 2018.